Glutathione S-transferase μ1 (GSTMI) status and bladder cancer risk: A meta-analysis

Mutagenesis

Volumn 15, Issue 5, 2000, Pages 399-404

  Johns, L E ^a   Houlston, R S ^a  

^a INSTITUTE OF CANCER RESEARCH   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

GLUTATHIONE TRANSFERASE;

ADULT; AGED; ARTICLE; BLADDER CANCER; BLADDER CARCINOGENESIS; CANCER RISK; CANCER SUSCEPTIBILITY; CASE CONTROL STUDY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DETOXIFICATION; ENVIRONMENTAL FACTOR; ENZYME DEFICIENCY; FEMALE; GENETIC POLYMORPHISM; GENETIC VARIABILITY; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL LITERATURE; META ANALYSIS; MODEL; OUTCOMES RESEARCH; POPULATION; PRIORITY JOURNAL; RISK FACTOR; SAMPLE;

CASE-CONTROL STUDIES; FEMALE; GENE DELETION; GENETIC PREDISPOSITION TO DISEASE; GLUTATHIONE TRANSFERASE; HUMANS; MALE; ODDS RATIO; POLYMORPHISM, GENETIC; RISK FACTORS; URINARY BLADDER NEOPLASMS;

EID: 0033828507     PISSN: 02678357     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. GSTM1 and GSTT1 genes are potential risk modifiers for bladder cancer
2. Genetic polymorphism of GSTM1, CYP2E1 and CYP2D6 in Egyptian bladder cancer patients
3. Genetic risk and carcinogen exposure: A common inherited defect of the carcinogen-metabolism gene glutathione S-transferase M1 (GSTM1) that increases susceptibility to bladder cancer
4. Glutathione S-transferase activity and subunit composition in transitional cell cancer and mucosa of the human bladder
5. Glutathione S-transferase M1 and its variants A and B as host factors of bladder cancer susceptibility: A case-control study
6. Combined analysis of inherited polymorphisms in arylamine N-acetyltransferase 2, glutathione S-transferases M1 and T1, microsomal epoxide hydrolase and cytochrome P450 enzymes as modulators of bladder cancer risk
7. Polymorphic enzymes of xenobiotic metabolism as modulators of acquired P53 mutations in bladder cancer
8. Homozygous deletion of gene for glutathione S-transferase M1 in bladder cancer
9. Meta-analysis in clinical trials
10. A simple approximation for calculating sample sizes for comparing independent proportions
11. GSTM1 and NAT2 genotypes and urinary mutagens in coke oven workers
12. N-Acetyltransferase 2 (NAT2) and glutathione S-transferase mu (GSTM1) in bladder-cancer patients in a highly industrialized area
13. Genetics of common cancers
14. Bladder cancer
15. Cytochrome P4501A1 gene polymorphism and homozygous deletion of the glutathione S-transferase M1 gene in urothelial cancer patients
16. Effects of glutathione S-transferase (GST) M1 and GSTT1 genotypes on urothelial cancer risk
17. Glutathione S-transferase GSTM1 and GSTT1 null genotypes as potential risk factors for urothelial cancer of the bladder
18. Human glutathione S-transferase mu (GST mu) deficiency as a marker for the susceptibility to bladder and larynx cancer among smokers
19. Influence of smoking in the glutathione-S-transferase M1 deficiency-associated risk for squamous cell carcinoma of the bladder in schistosomiasis patients in Egypt
20. Ethnic distribution of the glutathione transferase Mu 1-1 (GSTM1) null genotype in 1473 individuals and application to bladder cancer susceptibility
21. Glutathione S-transferase mu as a risk factor in bladder tumours
22. White blood cell DNA adducts, smoking and NAT2 and GSTM1 genotypes in bladder cancer: A case-control study
23. The glutathione S-transferase M1 (GSTM1) null genotype and benzidine-associated bladder cancer, urine mutagenicity and exfoliated urothelial cell DNA adducts
24. Genetic polymorphism of glutathione S-transferases M1 and T1 as a risk factor in lung and bladder cancers
25. Metabolic polymorphisms and cancer susceptibility
26. CYP2D6 genotyping and the association with lung cancer susceptibility
27. Relationship between the GSTM1 genetic polymorphism and susceptibility to bladder, breast and colon cancer